Mark A. Goldsmith sells 15,394 RVMD shares

Mark A. Goldsmith reported the sale of 15,394 common shares on 12/16/2025 for $1,182,525.52 as shown in the Form 144 excerpt.

Rhea-AI Filing Summary

Mark A. Goldsmith reported the sale of 15,394 common shares on 12/16/2025 for $1,182,525.52 as shown in the Form 144 excerpt. The filing names Morgan Stanley Smith Barney LLC with a listed quantity of 3,000 shares in the securities table.

Insights

Securities Compliance Analyst

Rule 144 notice documents an insider sale of 15,394 common shares.

The excerpt shows a reported disposition by Mark A. Goldsmith of 15,394 shares on 12/16/2025 for $1,182,525.52. The filing format and broker name are consistent with a Rule 144 notice for restricted or control securities.

Timing and proceeds treatment are limited to the lines shown; subsequent confirmations or broker confirmations would appear in other filings. This sale size does not by itself indicate a material change to capital structure based on the provided excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RVMD insider Mark A. Goldsmith report in the Form 144?

The filing reports Mark A. Goldsmith sold 15,394 common shares on 12/16/2025 for $1,182,525.52. The excerpt lists a broker name and a separate 3,000-share line in the securities table.

Does the Form 144 show who handled the sale for RVMD shares?

The excerpt names Morgan Stanley Smith Barney LLC and an address with a listed quantity of 3,000 shares. The filing text does not explicitly state execution details or whether that broker executed the full sale.

When was the RVMD insider transaction dated in the filing?

The transaction date shown in the excerpt is 12/16/2025. The filing also includes an earlier securities issue date of 11/25/2014 for founders' shares in the table.

How much gross proceeds did Mark A. Goldsmith receive according to the excerpt?

The excerpt reports proceeds of $1,182,525.52 tied to the reported sale of 15,394 common shares on 12/16/2025. The filing does not break out net proceeds or fees.

Is this Form 144 filing for RVMD an indication of major corporate changes?

This Form 144 documents an insider sale of 15,394 shares; filings of this type are routine. The excerpt does not disclose corporate-level transactions, governance changes, or material events beyond the reported disposition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001246842
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	REVOLUTION MEDICINES INC
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	6504816801
Name of Person for Whose Account the Securities are To Be Sold	THE REBECCA GOLDSMITH REVOCABLE TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	306060.00	198173397	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/25/2014	Founders Shares	ISSUER			3000	11/25/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK A GOLDSMITH 700 Saginaw Drive Redwood City CA 94063	Common	12/16/2025	15394	1182525.52

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark A Goldsmith
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)